Edition:
United Kingdom

Torrent Pharmaceuticals Ltd (TORP.NS)

TORP.NS on National Stock Exchange of India

1,836.60INR
18 Apr 2019
Change (% chg)

Rs-2.50 (-0.14%)
Prev Close
Rs1,839.10
Open
Rs1,839.15
Day's High
Rs1,848.75
Day's Low
Rs1,814.00
Volume
260,138
Avg. Vol
231,765
52-wk High
Rs1,962.00
52-wk Low
Rs1,303.55

Summary

Name Age Since Current Position

Samir Mehta

55 2014 Executive Chairman of the Board

Sudhir Mehta

60 2006 Non-Executive Chairman of the Board

Sudhir Menon

2018 Chief Financial Officer

Mahesh Agrawal

Vice President - Legal, Compliance Officer, Company Secretary

Chaitanya Dutt

63 2003 Director - Research and Development, Whole Time Director

Aman Mehta

71 2018 Executive Director

Nayantara Bali

52 2019 Independent Director

Shailesh Haribhakti

62 2014 Independent Director

Haigreve Khaitan

48 2014 Independent Director

Ameera Shah

38 2018 Independent Director

Biographies

Name Description

Samir Mehta

Shri. Samir Mehta is an Executive Chairman of the Board of Torrent Pharmaceuticals Ltd. He holds a Masters Degree in Business Management from the B. K. School of Business Management, Ahmedabad ( Gujarat University ).

Sudhir Mehta

Shri. Sudhir Mehta is Non-Executive Chairman of the Board of Torrent Pharmaceuticals Ltd. He has been associated with the Company since its inception. He has been instrumental in foreseeing these and developing an appropriate strategic response to it. His drive to excel is deeply rooted in his commitment to investors. As Chairman, Torrent Group, Mr. Mehta has provided the right strategic vision that has, time and again, borne rewards' for the Group. His other Directorship includes that of Torrent Power Ltd., Torrent Pipavav Generation Ltd., Torrent Energy Ltd. and Arvind Ltd. He is the Chairman of Securities Transfers & Investor Grievance Committee of the Company and also a member of Audit Committee & Investors Grievance Committee of Arvind Ltd.

Sudhir Menon

Shri. Sudhir Menon is Chief Financial Officer of the Company. A Chartered Accountant and Cost Accountant by qualification, Shri Sudhir Menon has more than 22 years of experience. He joined the Company in May, 2006 and had played a key role in setting of system based financial reporting structure, particularly in the marketing operations including the overseas subsidiaries of the Company. He was also one of the key member of the team involved in the various acquisition made by the Company. Hitherto, he was responsible for the functions like Corporate Finance, Financial reporting, Investors' relationship, Direct Taxation, Insurance, etc. and had also handled various other functions in the Company.

Mahesh Agrawal

Shri. Mahesh Agrawal is the Vice President - Legal, Compliance Officer, Company Secretary of the Torrent Pharmaceuticals Ltd.

Chaitanya Dutt

Dr. Chaitanya Dutt is Director - Research and Development, Whole Time Director of Torrent Pharmaceuticals Ltd. He is one of the key functionaries in the top management team and has been associated with the Company for last three decades. He holds an MD in Medicine and had practiced as a consulting physician before joining the Company in 1982. His experience spans areas of Pharma R&D, clinical research, manufacturing, quality assurance, etc. He has been instrumental in setting up the Research Centre of the Company. Under his prudent guidance and leadership, the Research Centre has achieved tremendous progress in the areas of discovery research as well as development work on formulations.

Aman Mehta

Nayantara Bali

Ms. Nayantara Bali is Independent Director of the Company. Ms. Nayantara Bali, has a Bachelors' degree of Arts in Economics from Stella Maris College, Chennai, India and has done Post Graduate Diploma in Business Management from Indian Institute of Management, Ahmedabad. She currently serves as the Director with ANV Consulting Pte. Ltd. Singapore (a boutique Management Consultancy that specializes in data analytics), wherein she specializes in P&L business management, strategy, brand management and diversity. She is a senior business leader with more than three decades of experience. She was associated with Procter & Gamble for over 28 years where she handled various General Management assignments both in India and Overseas. She is known for understanding complex situations and applying sharp strategic thinking, intuition and insight to actions that drive results. She led the diversity program in Asia for Procter & Gamble. She had also served as a director on the Boards of Procter & Gamble Gillette India and Procter & Gamble Health & Hygiene India.

Shailesh Haribhakti

Shri. Shailesh V. Haribhakti is Independent Director of Torrent Pharmaceuticals Ltd. He is a Fellow Chartered Accountant is the Managing Partner of Haribhakti & Co., Chartered Accountants and Chairman of BDO Consulting Private Limited. He served a three year term on the Standards Advisory Council of the International Accounting Standards Board. He is a Committee Member of Futures & Options segment of National Stock Exchange of India and a Member of the SEBI Committee on Disclosures and Accounting Standards. He serves as Member of Managing Committees of ASSOCHAM and IMC and Corporate Governance Committees of ASSOCHAM and CII and is Chairman of the Global Warming Committee of IMC. He is on the Board of Directors of Pantaloon Retail (India) Limited, Future Capital Holdings Limited, Hexaware Technologies Limited, ACC Limited, Ambuja Cements Limited, Mahindra Lifespace Developers Limited, Blue Star Limited, The Dhanalakshmi Bank Limited, J K Paper Limited, Everest Kanto Cylinder Limited, Raymond Limited, Future Value Retail Limited and L&T Finance Holdings Limited. Mr. Haribhakti is the Chairman of Audit Committee of L & T Finance Holdings Limited, Hexaware Technologies Limited, Ambuja Cement Limited, ACC Limited, Raymond Limited and member of Audit Committee of Blue Star Limited, The Dhanalakshmi Bank Limited, Mahindra Lifespace Developers Limited and Pantaloon Retail (India) Limited.

Haigreve Khaitan

Shri. Haigreve Khaitan is Independent Director of Torrent Pharmaceuticals Ltd. He is a Corporate and Commercial lawyer and a Partner of Khaitan & Co. Shri Khaitan heads Khaitan & Co.’s Mergers & Acquisitions (M&A) practice. He joined Khaitan & Co. in the year 1988. He spent considerable years of his initial practice in representing clients on litigation matters, and thereafter, he went on representing many clients on project fi nance and real estate transactions. Shri Khaitan presently focuses his practice on M&A, Private Equity, Venture Capital, Corporate Restructuring and advises various Indian and international clients on other strategic transactions.

Ameera Shah

Ms. Ameera Shah is Independent Director of the Company. She is having a degree in Finance from the University of Texas at Austin and has also completed the prestigious Owner-President Management Program at Harvard Business. School. She is the Promoter and Managing Director of Metropolis 1-Iealthcare Limited. Named amongst 'Asia's Most Powerful Women in Business' by Forbes Asia and 'Fifty Most Powerful Women in Business' by Fortune India, Ms. Shah is recognized as a global thought leader in the health care industry. An eminent industry spokesperson, she has been featured as a speaker in various National and International forums, industry events and conclaves organized by liM, Harvard Business School, TedX, CII, FICCI, Google, Twitter and other global entities. She has also beeJJ elected the Secretary of the IAPL (Indian Association of Pathology Laboratories) and has served as the Chairperson of the 'FICCI Health services Westem Subgroup' that drives policy decisions at the Center. Ms. Shah is also an advisor to many educational institutions (Baylor College of Medicine, liT Kanpur, liM Ahmedabad, NMIMS).

Basic Compensation

Name Fiscal Year Total

Samir Mehta

100,152,000

Sudhir Mehta

75,000,000

Sudhir Menon

--

Mahesh Agrawal

47,679,000

Chaitanya Dutt

7,372,000

Aman Mehta

--

Nayantara Bali

--

Shailesh Haribhakti

--

Haigreve Khaitan

--

Ameera Shah

--
As Of  31 Mar 2015